Full-Time

Executive Medical Affairs Director

Psychiatry

Confirmed live in the last 24 hours

Neurocrine Biosciences

Neurocrine Biosciences

1,001-5,000 employees

Biotechnology
Healthcare

Compensation Overview

$305.9k - $442.9kAnnually

+ Bonus + Equity Incentive Program

Senior, Expert

San Diego, CA, USA

Must reside locally; this is an office-based role.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • MD required and 8+ years of relevant experience
  • Preferred experience: Clinical Practice experience in Psychiatry
  • Highly effective communicator and collaborator, both internally and externally
  • Passion for education and addressing unmet medical needs in psychiatry
  • Expert in Psychiatry with prior leadership in pharma
  • Recognized as a subject matter expert and thought leader in psychiatry with extensive medical and business experience within a strategic organization
  • Requires broad and comprehensive expertise in leading-edge theories and techniques within strategic job function
  • Applies ingenuity and creativity to problem analysis and resolution in complicated and/or novel situations
  • Influences internal/external business and/or industry issues
  • Excellent leadership skills, mentors lower levels, and/or leads indirect teams
  • Exceptional interpersonal, communications, problem solving, analytical thinking, influencing skills
  • Sets longer-term vision for department or priority projects
  • Ability to meet multiple deadlines across a variety of projects/programs, with a high degree of accuracy and efficiency
  • Ability to apply advanced analytical thought and judgment
  • Proactive, innovative, with excellent problem-solving/decision making skills
  • Ability to work in a cross functional team and matrix environment
Responsibilities
  • Collect and synthesize insights from external stakeholders to understand education and data needs of providers, payers, patients, and caregivers to inform Medical Affairs strategic planning
  • Drive cross-functional alignment on medical affairs strategy, brand planning, and clinical development and data generation programs
  • Develop and execute medical strategies for Ingrezza and the broader psychiatry portfolio that aligns with business goals and market needs including oversight of tactical planning for field medical teams
  • Collaborate with cross-functional teams to generate real-world evidence, clinical data, and health economic research for products
  • Oversee Field Medical (e.g., MSL, CPL) strategy and performance for Ingrezza and priority pipeline assets including supporting strategic disease education and engagement planning
  • Advance the science related to company products and clinical development programs by growing relationships with Key Opinion Leaders (KOLs) and partnering with research organizations
  • Develop robust training initiatives to ensure the highest level of scientific technical acumen for all Medical Affairs team members
  • Partner with the Health Economics and Outcomes Research (HEOR) function in the creation and execution of research
  • Assess protocol grant submissions to the Investigator-Initiated Trial (IIT) program
  • Assist the Medical Communications function in creating and implementing publications and data dissemination plans, including medical congress tactics
  • Oversee the development and delivery of tailored medical programs and activities (e.g., presentations, publications, Advisory Boards) to support evidence-based decision-making among customers
  • Provide monthly status updates and team performance reports to the VP of Medical Affairs & HEOR on key initiatives
  • Ensure all Medical Affairs strategies, tactics, and initiatives are in compliance with regulations, guidelines, and ethical standards
  • Perform other duties as assigned, contributing to the overall success of Medical Affairs initiatives
Neurocrine Biosciences

Neurocrine Biosciences

View

Company Stage

IPO

Total Funding

N/A

Headquarters

San Diego, California

Founded

1992

Simplify Jobs

Simplify's Take

What believers are saying

  • CRENESSITY's FDA approval marks a significant advancement in CAH treatment.
  • Collaboration with Nxera Pharma strengthens Neurocrine's position in neuropsychiatric therapeutics.
  • Participation in major healthcare conferences boosts Neurocrine's visibility and investor relations.

What critics are saying

  • Increased competition in muscarinic agonist market may impact Neurocrine's market share.
  • Reliance on PANTHERx Rare for distribution poses potential partnership risks.
  • High cost of CRENESSITY could limit patient accessibility and market penetration.

What makes Neurocrine Biosciences unique

  • CRENESSITY is the first non-steroidal treatment for classic congenital adrenal hyperplasia.
  • Neurocrine's muscarinic agonist portfolio targets innovative treatments for neuropsychiatric disorders.
  • Partnership with Pantherx® Rare enhances patient access to rare disease treatments.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Parental Leave

Health Insurance

Dental Insurance

Vision Insurance

Paid Holidays